Plasma leptin or VEGF are little affected by maximal exercise at high altitude (5050 m)

G. Morici, A. Bonanno, A. Licciardi, G. Valli, C. Passino, D. Bonardi, V. Fasano, M. Agnesi, L. Bernardi, L. Chimenti, P. Palange, A. Cogo, M. R. Bonsignore (Palermo, Rome, Pisa, Milan, Pavia, Ferrara, Italy)

Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Session: Exercise in respiratory diseases and oxygen therapy
Session type: Thematic Poster Session
Number: 4391
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Morici, A. Bonanno, A. Licciardi, G. Valli, C. Passino, D. Bonardi, V. Fasano, M. Agnesi, L. Bernardi, L. Chimenti, P. Palange, A. Cogo, M. R. Bonsignore (Palermo, Rome, Pisa, Milan, Pavia, Ferrara, Italy). Plasma leptin or VEGF are little affected by maximal exercise at high altitude (5050 m). Eur Respir J 2010; 36: Suppl. 54, 4391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolic effects of hypoxia and sleep at high altitude (5050 m)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Exercise ventilatory efficiency at sea level (SL) predicts water load excretion at high altitude (HA)
Source: Eur Respir J 2004; 24: Suppl. 48, 326s
Year: 2004

Breathing pattern at rest and during different exercises at sea level (SL) and at high altitude (HA)
Source: Eur Respir J 2006; 28: Suppl. 50, 174s
Year: 2006

Effects of a daytrip to high altitude (2500m) in pulmonary hypertension.
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Increased body weight and reduced vital capacity correlate with augmentation of pulmonary hypertension during intermittent hypoxia at an altitude of 3800 m according to five years‘ follow up
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005


Polysomnographic nocturnal parameters in high altitude climbers: modulating effects of hypoxia training (HT) versus lower resting ventilation (LRV)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006

Reduced submaximal exercise performance in COPD patients at moderate altitude (2590m)
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014

Breathing patterns in mountaineers climbing to extreme altitude (7546m)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012

Effect of altitude on ventilatory pattern in élite climbers during the acclimatization at 5200m
Source: Eur Respir J 2005; 26: Suppl. 49, 349s
Year: 2005

Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Blood capillary volume as a determinant of high DLCO in subjects living at moderate altitude.
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Respiratory exercises during high altitude (HA) exposure help to maintain a better oxygen saturation (SpO2) counteracting the effects of hypoxia.
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019

Climbers usually resident at moderate altitude exhibit less oygen desaturation during rapid ascent to 4559 m
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015

Peak exercise increases plasma IL-6 without changes in muscle redox status in healthy young subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 289s
Year: 2002

Sildenafil increases exercise capacity by alleviation of hypoxic pulmonary hypertension at low altitude and at Mount Everest base camp
Source: Eur Respir J 2004; 24: Suppl. 48, 108s
Year: 2004

Estimation of effects of intermittent exposure to the altitude of 3200m on hypoxic pulmonary vasoreactivity
Source: Eur Respir J 2004; 24: Suppl. 48, 110s
Year: 2004

Significant alteration of blood coagulation in high altitude: the Kili study
Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans
Year: 2009


Effects of sildenafil and the association of sildenafil-sixtasentan on the NO/CO transfer factor in low landers exposed to high altitude
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011


Ventilatory exercise response at low altitude
Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues
Year: 2011


Reference values of the cardiopulmonary test of exercise at 2,240 meters of altitude
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017